medmix AG (SWX:MEDX)
Switzerland
· Delayed Price · Currency is CHF 10.34
-0.12 (-1.16%)
Apr 24, 2025, 4:46 PM CET
medmix AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 483.9 | 486.6 | 477.1 | 457.3 | 351.3 | Upgrade
|
| Revenue Growth (YoY) | -0.56% | 1.99% | 4.33% | 30.17% | -16.50% | Upgrade
|
| Cost of Revenue | 324.2 | 328.9 | 304.3 | 276.1 | 230.2 | Upgrade
|
| Gross Profit | 159.7 | 157.7 | 172.8 | 181.2 | 121.1 | Upgrade
|
| Selling, General & Admin | 116.4 | 119 | 103 | 95.6 | 81.3 | Upgrade
|
| Research & Development | 25.4 | 25.7 | 23.6 | 23 | 20.2 | Upgrade
|
| Other Operating Expenses | -1.3 | -4.3 | 5.4 | -0.2 | -0.8 | Upgrade
|
| Operating Expenses | 140.5 | 140.4 | 132 | 118.4 | 100.7 | Upgrade
|
| Operating Income | 19.2 | 17.3 | 40.8 | 62.8 | 20.4 | Upgrade
|
| Interest Expense | -12.1 | -10 | -6.5 | -8.1 | -7.7 | Upgrade
|
| Interest & Investment Income | 1.1 | 1.3 | 0.7 | - | 0.2 | Upgrade
|
| Earnings From Equity Investments | -5.7 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.4 | -2.5 | -4.5 | -3.3 | 1.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.9 | -1.3 | 0.2 | -0.3 | -0.2 | Upgrade
|
| EBT Excluding Unusual Items | 0.2 | 4.8 | 30.7 | 51.1 | 13.9 | Upgrade
|
| Merger & Restructuring Charges | -2.2 | -0.9 | -1.6 | -0.3 | -3.2 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 1.3 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.8 | 2 | -15.4 | 0.1 | 0.2 | Upgrade
|
| Asset Writedown | -5.2 | -3 | -1.5 | -0.9 | -0.5 | Upgrade
|
| Pretax Income | -6.4 | 2.9 | 12.2 | 51.3 | 10.4 | Upgrade
|
| Income Tax Expense | - | 2.2 | 0.6 | 7.3 | 0.8 | Upgrade
|
| Earnings From Continuing Operations | -6.4 | 0.7 | 11.6 | 44 | 9.6 | Upgrade
|
| Minority Interest in Earnings | -1 | -0.4 | - | - | - | Upgrade
|
| Net Income | -7.4 | 0.3 | 11.6 | 44 | 9.6 | Upgrade
|
| Net Income to Common | -7.4 | 0.3 | 11.6 | 44 | 9.6 | Upgrade
|
| Net Income Growth | - | -97.41% | -73.64% | 358.33% | -61.91% | Upgrade
|
| Shares Outstanding (Basic) | 41 | 41 | 41 | 41 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 41 | 41 | 41 | 41 | 34 | Upgrade
|
| Shares Change (YoY) | 0.50% | 0.25% | -0.15% | 20.14% | - | Upgrade
|
| EPS (Basic) | -0.18 | 0.01 | 0.28 | 1.07 | 0.28 | Upgrade
|
| EPS (Diluted) | -0.18 | 0.01 | 0.28 | 1.07 | 0.28 | Upgrade
|
| EPS Growth | - | -97.38% | -73.81% | 281.77% | - | Upgrade
|
| Free Cash Flow | 48.1 | 9.7 | 11.2 | 57.5 | 8.5 | Upgrade
|
| Free Cash Flow Per Share | 1.16 | 0.23 | 0.27 | 1.40 | 0.25 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | 0.500 | 0.500 | - | Upgrade
|
| Gross Margin | 33.00% | 32.41% | 36.22% | 39.62% | 34.47% | Upgrade
|
| Operating Margin | 3.97% | 3.55% | 8.55% | 13.73% | 5.81% | Upgrade
|
| Profit Margin | -1.53% | 0.06% | 2.43% | 9.62% | 2.73% | Upgrade
|
| Free Cash Flow Margin | 9.94% | 1.99% | 2.35% | 12.57% | 2.42% | Upgrade
|
| EBITDA | 64 | 60.8 | 80.2 | 105 | 55.6 | Upgrade
|
| EBITDA Margin | 13.23% | 12.50% | 16.81% | 22.96% | 15.83% | Upgrade
|
| D&A For EBITDA | 44.8 | 43.5 | 39.4 | 42.2 | 35.2 | Upgrade
|
| EBIT | 19.2 | 17.3 | 40.8 | 62.8 | 20.4 | Upgrade
|
| EBIT Margin | 3.97% | 3.55% | 8.55% | 13.73% | 5.81% | Upgrade
|
| Effective Tax Rate | - | 75.86% | 4.92% | 14.23% | 7.69% | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.